Literature DB >> 9236129

Helix proximity and ligand-induced conformational changes in the lactose permease of Escherichia coli determined by site-directed chemical crosslinking.

J Wu1, H R Kaback.   

Abstract

N and C-terminal halves of lactose permease, each with a single-Cys residue, were co-expressed, and crosslinking was studied. Iodine or N,N'-o-phenylenedimaleimide (o-PDM; rigid 6 A), crosslinks Asn245 Cys (helix VII) and Ile52 --> Cys or Ser53 --> Cys (helix II). N,N'-p-phenylenedimaleimide (p-PDM; rigid 10 A) crosslinks the 245/53 Cys pair weakly, but does not crosslink 245/52, and 1,6-bis-maleimidohexane (BMH; flexible 16 A) crosslinks both pairs less effectively than o-PDM. Thus, 245 is almost equidistant from 52 and 53 by up to about 6 A. BMH or p-PDM crosslinks Gln242 --> Cys and Ser53 --> Cys, but o-PDM is ineffective, indicating that distance varies by up to 10 A. Ligand binding increases crosslinking of 245/53 with p-PDM or BMH, has little effect with o-PDM and decreases iodine crosslinking. Similar effects are observed with 245/52. Ligand increases 242/53 crosslinking with p-PDM or BMH, but no crosslinking is observed with o-PDM. Therefore, ligand induces a translational or scissors-like displacement of the helices by 3-4 A. Crosslinking 245/53 inhibits transport indicating that conformational flexibility is important for function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236129     DOI: 10.1006/jmbi.1997.1099

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  Enhanced internal dynamics of a membrane transport protein during substrate translocation.

Authors:  K Doring; T Surrey; S Grünewald; E John; F Jähnig
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

2.  Structural model for 12-helix transporters belonging to the major facilitator superfamily.

Authors:  Teruhisa Hirai; Jürgen A W Heymann; Peter C Maloney; Sriram Subramaniam
Journal:  J Bacteriol       Date:  2003-03       Impact factor: 3.490

3.  An approach to membrane protein structure without crystals.

Authors:  Paul L Sorgen; Yonglin Hu; Lan Guan; H Ronald Kaback; Mark E Girvin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

4.  Site-directed alkylation of LacY: effect of the proton electrochemical gradient.

Authors:  Yiling Nie; Natalia Ermolova; H Ronald Kaback
Journal:  J Mol Biol       Date:  2007-09-11       Impact factor: 5.469

5.  An early event in the transport mechanism of LacY protein: interaction between helices V and I.

Authors:  Yonggang Zhou; M Gregor Madej; Lan Guan; Yiling Nie; H Ronald Kaback
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

6.  Changes in secondary structures and acidic side chains of melibiose permease upon cosubstrates binding.

Authors:  Xavier León; Raymonde Lemonnier; Gérard Leblanc; Esteve Padrós
Journal:  Biophys J       Date:  2006-09-29       Impact factor: 4.033

7.  Identification of the intracellular gate for a member of the equilibrative nucleoside transporter (ENT) family.

Authors:  Raquel Valdés; Johannes Elferich; Ujwal Shinde; Scott M Landfear
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

8.  A polytopic membrane protein displays a reversible topology dependent on membrane lipid composition.

Authors:  Mikhail Bogdanov; Phillip N Heacock; William Dowhan
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

9.  Site-directed alkylation studies with LacY provide evidence for the alternating access model of transport.

Authors:  Xiaoxu Jiang; Yiling Nie; H Ronald Kaback
Journal:  Biochemistry       Date:  2011-02-08       Impact factor: 3.162

10.  Substrate-specific binding and conformational changes involving Ser313 and transmembrane domain 8 of the human reduced folate carrier, as determined by site-directed mutagenesis and protein cross-linking.

Authors:  Zhanjun Hou; Jianmei Wu; Jun Ye; Christina Cherian; Larry H Matherly
Journal:  Biochem J       Date:  2010-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.